Belvedere Trading
OTLK icon

Belvedere Trading’s Outlook Therapeutics OTLK Stock Holding History

Belvedere Trading’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.95K Buy
+5,000
New +$3.1K ﹤0.01% 960

Other funds holding OTLK

GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
CKAIS
Christensen King & Associates Investment Services Richland, Washington $252M AUM 20.51% 1-Year Est. Return
FCC
Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return
OFS
Orrstown Financial Services Harrisburg, Pennsylvania $674M AUM 23.23% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
FTWA
Fifth Third Wealth Advisors Cincinnati, Ohio $3.58B AUM 34.55% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Belvedere Trading's OTLK Position: Q2 2026 in Review

Belvedere Trading opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 40,899 shares worth $65K. The stake represents ﹤0.01% of the portfolio and ranks #783 among its holdings.

16 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Belvedere Trading held 40,899 shares of Outlook Therapeutics worth $65K as of Q2 2026.
  • Outlook Therapeutics was a new Belvedere Trading position in Q2 2026.
  • Outlook Therapeutics made up ﹤0.01% of Belvedere Trading's portfolio in Q2 2026, its #783 holding.
  • 16 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Belvedere Trading's 13F filing for Q2 2026, filed 31 Jul 2026.